JAGX
Jaguar Health, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.60
−14.06%Margins
Gross margin
82.3%
EBITDA margin
-144.1%
EBIT margin
-90.2%
Net margin
-131.8%
FCF margin
-24.3%
-554.0%
Return on equity
-107.2%
Return on assets
-107.9%
Return on invested capital
0.78x
Asset turnover
-$6.7M
Cash from operations
$1.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026